Stereotactic body radiation therapy (SBRT) is increasingly being used to manage primary and metastatic liver tumors4,5,6. Accurately accounting for respiratory motion is imperative when targeting liver tumors with radiation.
This study demonstrates the feasibility of using hepatobiliary contrast-enhanced 4D MRI to delineate gross liver tumors directly throughout the respiratory cycle. The lower coverage of directly visualized MRI targets in plans generated using standard of care 4D CT-derived targets suggests that the adoption of 4D MRI for motion management may improve radiation treatment of liver lesions and reduce the risk of marginal misses.
4D MRI for Treatment Planning
of Liver TumorsJessica Scholey1; Horatio Thomas1; Xin Miao2;
Dianne Ferguson3; Mary Feng1
Did this information help you?
1
Department of Radiation Oncology, University of California, San Francisco, CA, USA
2
Siemens Medical Solutions USA Inc., Boston, MA, USA
3
Department of Radiation Oncology, Brigham and Women’s Hospital, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
4
Mahadevan A, Blanck O, Lanciano R, et al. Stereotactic Body Radiotherapy (SBRT) for liver metastasis – clinical outcomes from the international multi-institutional RSSearch® Patient Registry. Radiation Oncology. 2018;13(1):1-11.
5
Ohri N, Tomé WA, Romero AM, et al. Local control after stereotactic body radiation therapy for liver tumors. International Journal of Radiation Oncology* Biology* Physics. 2021;110(1):188-195.
6
Doi H, Beppu N, Kitajima K, Kuribayashi K. Stereotactic body radiation therapy for liver tumors: current status and perspectives. Anticancer Research. 2018;38(2):591-599.